Related Experiment Video
Updated: Feb 19, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Targeted Inhibition of the NCOA1/STAT6 Protein-Protein Interaction
Yeongju Lee1, Heeseok Yoon2, Sung-Min Hwang3
1Department of Chemistry and Division of Advanced Material Science, Pohang University of Science and Technology (POSTECH) , Pohang 37673, South Korea.
Abstract:
The complex formation between transcription factors (TFs) and coactivator proteins is required for transcriptional activity, and thus disruption of aberrantly activated TF/coactivator interactions could be an attractive therapeutic strategy. However, modulation of such protein-protein interactions (PPIs) has proven challenging. Here we report a cell-permeable, proteolytically stable, stapled helical peptide directly targeting nuclear receptor coactivator 1 (NCOA1), a coactivator required for the transcriptional activity of signal transducer and activator of transcription 6 (STAT6). We demonstrate that this stapled peptide disrupts the NCOA1/STAT6 complex, thereby repressing STAT6-mediated transcription. Furthermore, we solved the first crystal structure of a stapled peptide in complex with NCOA1. The stapled peptide therefore represents an invaluable chemical probe for understanding the precise role of the NCOA1/STAT6 interaction and an excellent starting point for the development of a novel class of therapeutic agents.
Insights
A novel stapled peptide disrupts the NCOA1/STAT6 complex, inhibiting STAT6-mediated transcription. This peptide serves as a chemical probe and a potential therapeutic lead for targeting protein-protein interactions.
Area of Science:
- Molecular Biology
- Structural Biology
- Drug Discovery
Background:
- Transcription factor (TF) and coactivator protein complex formation is crucial for transcriptional activity.
- Targeting aberrant TF/coactivator interactions presents a therapeutic strategy, but modulating protein-protein interactions (PPIs) is challenging.
Purpose of the Study:
- To develop a cell-permeable, stable peptide targeting nuclear receptor coactivator 1 (NCOA1).
- To investigate the disruption of the NCOA1/STAT6 complex and its effect on STAT6-mediated transcription.
- To elucidate the structural basis of stapled peptide interaction with NCOA1.
Main Methods:
- Design and synthesis of a stapled helical peptide targeting NCOA1.
- Assessment of the peptide's ability to disrupt the NCOA1/STAT6 complex in cells.
- Determination of the crystal structure of the stapled peptide in complex with NCOA1.
Main Results:
- A cell-permeable, proteolytically stable stapled peptide was developed that targets NCOA1.
- The stapled peptide successfully disrupted the NCOA1/STAT6 complex, repressing STAT6-mediated transcription.
- The first crystal structure of a stapled peptide bound to NCOA1 was determined.
Conclusions:
- The stapled peptide is an effective chemical probe for studying the NCOA1/STAT6 interaction.
- This peptide represents a promising starting point for developing new therapeutics targeting PPIs.
Related Concept Videos
Inhibition of Cdk Activity
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Types of RNA
RNA Performs Diverse...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....

